Zobrazeno 1 - 10
of 63
pro vyhledávání: '"K. J. Olsen"'
Autor:
Signe Mosegaard, Krishna S. Twayana, Simone W. Denis, Jeffrey Kroon, Bauke V. Schomakers, Michel vanWeeghel, Riekelt H. Houtkooper, Rikke K. J. Olsen, Christian K. Holm
Publikováno v:
FASEB BioAdvances, Vol 6, Iss 9, Pp 337-350 (2024)
Abstract Stimulation of mammalian cells with inflammatory inducers such as lipopolysaccharide (LPS) leads to alterations in activity of central cellular metabolic pathways. Interestingly, these metabolic changes seem to be important for subsequent re
Externí odkaz:
https://doaj.org/article/7938490e07d84a48856606bf02802cfc
Autor:
Paula Fernandez-Guerra, Ana C. Gonzalez-Ebsen, Susanne E. Boonen, Julie Courraud, Niels Gregersen, Jesper Mehlsen, Johan Palmfeldt, Rikke K. J. Olsen, Louise Schouborg Brinth
Publikováno v:
Biomolecules, Vol 11, Iss 7, p 961 (2021)
Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a heterogeneous, debilitating, and complex disease. Along with disabling fatigue, ME/CFS presents an array of other core symptoms, including autonomic nervous system (ANS) dysfunction, su
Externí odkaz:
https://doaj.org/article/552a3a7d9e59482098c3ee6da5e71c0a
Autor:
Maria Tolomeo, Guglielmina Chimienti, Martina Lanza, Roberto Barbaro, Alessia Nisco, Tiziana Latronico, Piero Leone, Giuseppe Petrosillo, Grazia Maria Liuzzi, Bryony Ryder, Michal Inbar-Feigenberg, Matilde Colella, Angela M. S. Lezza, Rikke K. J. Olsen, Maria Barile
Publikováno v:
Free Radical Research. 56:511-525
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::dfc0568165009f65462f8ca63eb8c5e9
https://doi.org/10.1080/10715762.2022.2146501
https://doi.org/10.1080/10715762.2022.2146501
Autor:
Kai Muru, Karit Reinson, Kadi Künnapas, Hardo Lilleväli, Zahra Nochi, Signe Mosegaard, Sander Pajusalu, Rikke K. J. Olsen, Katrin Õunap
Publikováno v:
Molecular Genetics & Genomic Medicine, Vol 7, Iss 9, Pp n/a-n/a (2019)
Abstract Background Multiple acyl‐CoA dehydrogenase deficiency (MADD), also known as glutaric aciduria type II, is a mitochondrial fatty acid oxidation disorder caused by variants in ETFA, ETFB, and ETFDH. Recently, riboflavin transporter genes and
Externí odkaz:
https://doaj.org/article/037c94e70446405288bdd9eee3164556
Prokaryotic CRISPR-Cas adaptive immune systems rely on small non-coding RNAs derived from CRISPR loci to recognize and destroy complementary nucleic acids. However, the mechanism of Type IV CRISPR RNA (crRNA) biogenesis is poorly understood. To disse
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e3c92c36683782193ae8ac3dd399aafb
Autor:
N. Taouatas, Christine í Dali, E.R. Danielsen, A. M. Thuesen, Carsten Thomsen, Allan M. Lund, K. J. Olsen, Jan-Eric Månsson, Jens Fogh, Line Borgwardt
Publikováno v:
Clinical Genetics. 89:489-494
Alpha-mannosidosis (AM) (OMIM 248500) is a rare lysosomal storage disease. The understanding of the central nervous system (CNS) pathology is limited. This study is the first describing the CNS pathology and the correlation between the CNS pathology
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1601d8e224b834f1b36e6a6b6dba6bca
https://doi.org/10.1111/cge.12642
https://doi.org/10.1111/cge.12642
Autor:
K. Glettler, Julia K. Mader, Thomas R. Pieber, Gerd Koehler, Stefan Korsatko, Gerlies Bock, K. J. Olsen, Barbara Semlitsch, Andrea Wutte
Publikováno v:
Diabetes, Obesity and Metabolism. 15:241-245
AIMS To compare the pharmacodynamic properties of insulin detemir (detemir) and neutral protamine lispro (NPL) insulin using a euglycaemic glucose clamp. METHODS In a double-blind, crossover study, 30 patients with C-peptide negative type 1 diabetes
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::95ea16523d45e8a6d00be921474ce9ab
https://doi.org/10.1111/dom.12016
https://doi.org/10.1111/dom.12016
Autor:
Øivind Nilssen, Yasmina Amraoui, Allan M. Lund, Flemming Wibrand, Michael Beck, Christine í Dali, K. J. Olsen, Line Borgwardt, Laila Arash, Hilde Monica Frostad Riise Stensland, Helle Bagterp Klenow, Jens Fogh
Publikováno v:
Orphanet Journal of Rare Diseases
Background Alpha-mannosidosis is caused by mutations in MAN2B1, leading to loss of lysosomal alpha-mannosidase activity. Symptoms include intellectual disabilities, hearing impairment, motor function disturbances, facial coarsening and musculoskeleta
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::295a6c82f13ddb2e419c09c68cadcef8
http://europepmc.org/articles/PMC4465300
http://europepmc.org/articles/PMC4465300
Autor:
L, Borgwardt, E R, Danielsen, C, Thomsen, J E, Månsson, N, Taouatas, A M, Thuesen, K J, Olsen, J, Fogh, C I, Dali, A M, Lund
Publikováno v:
Clinical genetics. 89(4)
Alpha-mannosidosis (AM) (OMIM 248500) is a rare lysosomal storage disease. The understanding of the central nervous system (CNS) pathology is limited. This study is the first describing the CNS pathology and the correlation between the CNS pathology
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::fe094e44906a78b1af3660e8b616c59d
https://pubmed.ncbi.nlm.nih.gov/26212233
https://pubmed.ncbi.nlm.nih.gov/26212233
Publikováno v:
Journal of inherited metabolic disease. 38(6)
Alpha-mannosidosis (OMIM 248500) (AM) is a rare lysosomal storage disease caused by a deficiency of the alpha-mannosidase enzyme. The typical signs consist of hearing impairment, intellectual disabilities, coarse facial features and motor function di
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f26c7379738605c0a69ef8eb8ca2bcad
https://pubmed.ncbi.nlm.nih.gov/26016802
https://pubmed.ncbi.nlm.nih.gov/26016802